Tochigi, Japan

Noboru Kwaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Snow Brand Milk Products Co., Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noboru Kwaguchi. Retrieved from https://idiyas.com/inventor/noboru-kwaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noboru Kwaguchi: Innovator in Isoquinoline Derivatives

Introduction

Noboru Kwaguchi is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work focuses on isoquinoline derivatives, which have important applications in medicinal chemistry.

Latest Patents

Noboru Kwaguchi holds a patent for isoquinoline derivatives and salts thereof. The invention provides novel compounds with a specific structure, wherein R1 is a guanidinobenzoyloxy group and R2 can be a hydrogen atom, hydroxy, cyano, or various other groups. These compounds are particularly useful as protease inhibitors, serving as anti-trypsin agents.

Career Highlights

Kwaguichi is associated with Snow Brand Milk Products Co., Ltd., where he applies his expertise in chemistry to innovate and develop new products. His work has contributed to advancements in the field, showcasing his dedication to research and development.

Collaborations

He has collaborated with notable coworkers such as Yasuyoshi Takeshita and Hiroshi Nakamura. Their combined efforts have led to significant advancements in their respective fields.

Conclusion

Noboru Kwaguchi's contributions to the field of chemistry, particularly through his patent on isoquinoline derivatives, highlight his role as an innovator. His work continues to influence the development of new medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…